HSBC analyst Vikram Gandhi downgraded KKR (KKR) to Hold from Buy with a price target of $173, up from $153. While the firm views KKR as a ...

Private markets are set for a “golden age” even as investors adapt to a world of higher interest rates thanks to the vast ...

Private equity firm KKR & Co. Inc. has invested $250 million in Henry Schein Inc., Long Island’s largest publicly traded ...

Private equity firm KKR has taken a large stake in Henry Schein and reached a deal to add members to the company's board, the ...

The private-equity firm KKR has taken a big stake in the medical- and dental-supply company Henry Schein and plans to work ...

KKR & Co. has taken a 12% stake in Henry Schein Inc. and will work with the company to improve operations at the world’s ...

In the assessment of 12-month price targets, analysts unveil insights for KKR, presenting an average target of $169.0, a high estimate of $185.00, and a low estimate of $151.00. This current average ...

The firm in December brought on its first head of defined contribution, signifying a focus to get into 401(k)s and other ...

Learn more about whether KKR & Co. Inc. or UBS Group AG is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Henry Schein, Inc. (NASDAQ:HSIC) shares are trading higher on Wednesday. The medical and dental supplies distributor ...

KKR & Co. Inc. hit a new 52-week high, surpassing its previous peak of $165.83, which the company achieved on January 24th.

(Reuters) - Private-equity firm KKR has taken a large stake in Henry Schein and plans to work with the distributor of ...